Parabilis Medicines, Inc. (PBLS)

NASDAQ: PBLS · Real-Time Price · USD

25.85

-0.18 (-0.69%)

At close: Jun 18, 2026, 4:00 PM EDT

25.92

+0.07 (0.27%)

After-hours: Jun 18, 2026, 7:58 PM EDT

Parabilis Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	27.71	47.28
Short-Term Investments	-	40.69
Cash & Short-Term Investments	27.71	87.98
Cash Growth	-68.50%	-
Other Receivables	-	0.36
Total Trade Receivables	-	0.36
Other Current Assets	1.65	3.87
Total Current Assets	29.36	92.21
Net Property, Plant & Equipment	46.08	52.93
Other Long-Term Assets	5.39	4.12
Total Assets	80.82	149.25
Accounts Payable	17.27	9.51
Accrued Expenses	18.63	13.52
Current Portion of Long-Term Debt	13.08	2.5
Current Portion of Leases	7.81	6.88
Total Current Liabilities	56.79	32.41
Long-Term Debt	-	12.79
Long-Term Leases	37.81	44.03
Other Long-Term Liabilities	2.74	3.58
Total Long-Term Liabilities	40.55	60.4
Total Liabilities	97.34	92.81
Additional Paid-in Capital	15.01	11.66
Accumulated Other Comprehensive Income	-	0.02
Retained Earnings	-541.5	-395.62
Total Common Shareholders' Equity	-526.5	-383.94
Minority Interest	509.97	440.38
Shareholders' Equity	-16.52	56.44
Total Liabilities & Equity	80.82	149.25

SEC Filings: 10-K · 10-Q